Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference


Werte in diesem Artikel
Aktien

91.50 EUR 0.00 EUR 0.0 %

BOSTON, Dec. 7, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 9, 2024 at 9:45am Pacific time.

The public may access Mr. Simon's presentation live via audio webcast at:
https://jpmorgan.metameetings.net/events/healthcare24/sessions/49347-haemonetics-corporation/webcast?gpu_only=true&kiosk=true

The live webcast can also be accessed under the Events & Presentations section of the Company's Investor Relations website. The replay of the presentation will be available for 30 days using the link provided above and on Investor Relations website shortly after the live event.

ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:


Olga Guyette, Sr. Director-Investor Relations & Treasury

David Trenk, Manager-Investor Relations

(781) 356-9763

(203) 733-4987

olga.guyette@haemonetics.com

david.trenk@haemonetics.com



Media Contact:
Josh Gitelson, Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com


 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-42nd-annual-jp-morgan-healthcare-conference-302009459.html

SOURCE Haemonetics Corporation

Aktuelle Haemonetics Aktie News

Werbung

Haemonetics Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Haemonetics nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
Datum Rating Analyst
07.08.19 Haemonetics Outperform Barrington Research
08.05.19 Haemonetics Outperform Barrington Research
09.08.18 Haemonetics Outperform Barrington Research
07.02.18 Haemonetics Outperform Barrington Research
08.11.17 Haemonetics Outperform Barrington Research

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.